Schonfeld Strategic Advisors LLC Gossamer Bio, Inc. Transaction History
Schonfeld Strategic Advisors LLC
- $14.6 Billion
- Q2 2024
A detailed history of Schonfeld Strategic Advisors LLC transactions in Gossamer Bio, Inc. stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 1,156,236 shares of GOSS stock, worth $1.03 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,156,236
Previous 180,558
540.37%
Holding current value
$1.03 Million
Previous $213,000
388.26%
% of portfolio
0.01%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding GOSS
# of Institutions
102Shares Held
175MCall Options Held
453KPut Options Held
543K-
Nea Management Company, LLC Timonium, MD18.1MShares$16.1 Million1.54% of portfolio
-
Artal Group S.A. Luxembourg, N413.3MShares$11.8 Million0.76% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$10.5 Million0.0% of portfolio
-
Octagon Capital Advisors LP New York, NY9.19MShares$8.18 Million1.91% of portfolio
-
Arch Venture Management, LLC Chicago, IL8.06MShares$7.17 Million4.25% of portfolio
About Gossamer Bio, Inc.
- Ticker GOSS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 93,954,000
- Market Cap $83.6M
- Description
- Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...